Ignite Creation Date:
2024-05-06 @ 3:17 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04589429
Status:
UNKNOWN
Last Update Posted:
2021-03-01
First Post:
2020-09-27
Brief Title:
Adding Nalbuphine for Control of Intrathecal Morphine Pruritus
Sponsor:
Minia University
Organization:
Minia University
Study Overview
Official Title:
Does Adding Nalbuphine to Intrathecal Morphine Reduce Morphine Induced Pruritus A Randomized Double Blind Controlled Study
Status:
UNKNOWN
Status Verified Date:
2021-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Intrathecal morphine causes intense itching which is very bothersome Nalbuphine antagonizes this effect when given intravenously This trial is to find out if nalbuphine added to intrathecal morphine has an effect on morphine related pruritus while still maintaining adequate analgesia
Detailed Description:
The study will be performed in MiniaUniversity Hospitals after obtaining approval from the local ethics committee All patients will have a peripheral IV cannula 18 G inserted standard non-invasive monitors will be applied Patients undergoing major abdominal surgery will be divided into 2 groups to receive intrathecal morphine 300 micrograms with or without nalbuphine 1mg prior to anesthesia General anesthesia is then given to patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None